Lethal complications of preeclampsia and eclampsia;Smrtelné komplikace preeklampsie a eklampsie

Ceska Gynekologie

Volumn 67, Issue 6, 2002, Pages 365-371

  Srp, B ^a   Velebil, P ^a   Kvasnicka J ^a  

^a NONE

Author keywords

Eclampsia; Epideimology; Maternal mortality; Operative delivery; Preeclampsia

Indexed keywords

ARTICLE; BRAIN HEMORRHAGE; CESAREAN SECTION; CLINICAL ARTICLE; COMA; CONVULSION; CZECH REPUBLIC; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; FEMALE; FETUS MORTALITY; HELLP SYNDROME; HIGH RISK POPULATION; HUMAN; INSTRUMENTAL DELIVERY; KIDNEY FAILURE; LIVER DISEASE; MATERNAL AGE; MATERNAL CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPARA; MULTIPLE PREGNANCY; NEPHROSIS; PARITY; PREECLAMPSIA; PREGNANCY TERMINATION; PUERPERIUM; SOLUTIO PLACENTAE;

EID: 0036947276     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Aoki, N., Hasegawa, H.: On the revised form of the confirmatory test in diagnostic criteria for DIC. Annual Report of the Research Committee on Coagulation Disorders. Ministry of Health and Welfare of Japan, Tokyo 1988, s. 37-41.
2. Asakura, H., Ontachi, Y., Mizutani, T. et al.: Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases. Blood Coagul. Fibrinolysis., 12, 2001, s. 1-8.
3. Bernard, G. R., Vincent, J. L., Laterre, P. F. et al.: Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS Study Group): Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med., 344, 2001, s. 699-709.
4. Casper, F., Zepp, F., Seufert, R.: Das HELLP - Syndröm. Gynakologe, 1990, 23, s. 29-32.
5. Esmon, C. T.: The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness. Crit. Care, 5, 2001, Suppl 2, s. 7-12.
6. Kvasnička, J., Srp, B.: Doporučení k prevenci a léčbě poruch hemostázy v těhotenství a šestinedělí. Čes. Gynek., 56, 4, 1991, s. 302-307.
7. Okajima, K., Sakamoto, Y., Uchiba, M.: Heterogenity in the incidence and clinical manifestations of disseminated intravascular coagulation: a 204cases. Am. J. Hematol., 65, 2000, s. 215-222.
8. Pritchard, J. A., Weisman, R., Ratnoff, O. D., Vosbrugh, G. J.: Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N. E. J. Med., 250, 1994, s. 89-98.
9. Sibai, B. M., Ramadan, M. K., Usta, I., Salama, M., Mercer, B. M., Friedman, S.: Maternal morbidity and mortality in 442 pragnancies with hemolysis, levated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol. 169, 1993, s. 1000-1006.
10. Souter, P. J., Thomas, S., Hubbard, A. R., Poole, S., Romisch, J., Gray, E.: Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit. Care Med., 29, 2001, s. 134-139.
11. Srp, B., Velebil, P.: Proportion of caesarea sections and main causes of maternal mortality during 1978-1997 in the Czech Republic. Čes. Gynek., 64, 2000, 5, s. 219-226.
12. Srp, B., Velebil, P.: Koagulopatie - Hlavníi příčina mateřskéd úmrtnosti. Čes. Gynek., 66, 2001, s. 104-112.
13. Srp, B., Velebil, P.: Mateřská úmrtnost v České republice v letech 1978-1997. Čes. Gynek., 65, 2000, 5, s. 307-316.
14. Strauss, H. G., Scheller, C.: Ropke HELLP: Syndrom am 6. Wochenbettstag. Schilderung von Kasuistiken. Zentralblatt für Gynaekologie, 116, 1994, s. 210-212.
15. Weinstein, L.: Syndrome of helolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol., 142, 1982; s. 159-167.